Table 2.
Baseline characteristics of included studies
| No. of studies | Total | No ESC | ESC | ||||
|---|---|---|---|---|---|---|---|
| n | Pooled value (%)* | n | Pooled value (%)* |
n | Pooled value (%)* |
||
| Patient characteristics | |||||||
| Men | 27 | 573 of 814 | 70.4 | 537 of 760 | 70.7 | 36 of 54 | 67 |
| Age (years) | 27 | 804 | 62.9† | 750 | 63.4† | 54 | 56† |
| BMI (kg/m2) | 10 | 197 | 25.4† | 149 | 25.5† | 48 | 25† |
| Neoadjuvant radiotherapy | 27 | 369 of 811 | 45.5 | 346 of 757 | 45.7 | 23 of 54 | 43 |
| Indication for primary surgery | |||||||
| Colorectal cancer | 28 | 613 of 817 | 75.0 | 582 of 763 | 76.3 | 31 of 54 | 57 |
| IBD | 28 | 66 of 817 | 8.1 | 43 of 763 | 5 | 23 of 54 | 43 |
| Other | 28 | 134 of 817 | 16.4 | 134 of 763 | 17.6 | 0 of 54 | 0 |
| Primary stoma (created during index surgery) | 24 | 577 of 776 | 74.4 | 553 of 722 | 73.6 | 24 of 54 | 44 |
| Secondary stoma (created after index surgery) | 23 | 119 of 687 | 17.3 | 86 of 613 | 14.0 | 30 of 54 | 56 |
| EVT in outpatient setting | 9 | 216 of 423 | 51.1 | 216 of 423 | 51.1 | 0 | 0 |
| Duration of follow-up (months) | 13 | 246 | 19.4† | 170 | 17.5† | 54 | 30† |
*Unless indicated otherwise; †mean value. ESC, early surgical closure; n, number of patients; IBD, inflammatory bowel disease; EVT, endoscopic vacuum therapy.